Vincristine revisited

Crit Rev Oncol Hematol. 1999 Feb;29(3):267-87. doi: 10.1016/s1040-8428(98)00023-7.

C E Gidding ¹, S J Kellie, W A Kamps, S S de Graaf

Affiliations

Affiliation

1 Children's Cancer Center, Beatrix Children's Hospital, Groningen, The Netherlands.

PMID: 10226730 DOI: 10.1016/s1040-8428(98)00023-7

Products

Cat. No.

Product Name

Description

Target

Research Area
HY-N0488

Vincristine sulfate

99.81%, Antineoplastic Agent

Microtubule/Tubulin; Apoptosis

Cancer
HY-N0488S1

Vincristine-d₃-ester sulfate

≥99.0%, Stable Isotope

Microtubule/Tubulin; Apoptosis

Cancer
HY-N0488S2

Vincristine-d₆ sulfate

Stable Isotope

Isotope-Labeled Compounds; Microtubule/Tubulin; Apoptosis

Cancer
HY-N0488S

Vincristine-d₃ sulfate

Stable Isotope

Isotope-Labeled Compounds; Microtubule/Tubulin; Apoptosis

Cancer

MedChemExpress Magic Cece

MedChemExpress: Contact Us; About Us; Headquarters; Distributors; Statement on False Report; Careers

Customer Support: Technical Support; Service; Ordering Information; Easy Return; Shipping Rates & Policies; Intellectual Property Promise

Resources: Free Sample; Resources; Molarity Calculator; Dilution Calculator; Terms & Conditions; Reconstitution Calculator; Specific Activity Calculator

Subscribe to our E-newsletter

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.

Copyright © 2013-2024 MedChemExpress. All Rights Reserved.: Site Map Privacy Policy

Join with us